Establishes, under the Federal Food, Drug, and Cosmetic Act, a standard for determining substantial evidence of a drug's effectiveness for purposes of revocation of an approval of a new drug application under such Act, or repeal of a certification of antibiotics under such Act. (Amends 21 U.S.C. 355)
Introduced in House
Introduced in House
Referred to House Committee on Interstate and Foreign Commerce.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line